Skip to main content

pathology microbiology and immunology Archives

Skaar receives American Asthma Foundation award

Aug. 6, 2015—Eric Skaar, Ph.D., MPH, the Ernest W. Goodpasture Professor of Pathology, has received a Scholar Award from the American Asthma Foundation (AAF).

Read more


How to trick a wily virus

Jul. 24, 2015—Vanderbilt investigators have discovered how human antibodies induced during testing of an experimental “bird flu” vaccine kill the virus.

Read more


Medical societies honor VUMC’s Cover, Williams

Jun. 11, 2015—Two physicians from Vanderbilt University have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).

Read more


Study identifies C. diff toxin receptor, suggests new treatment approaches

Jun. 4, 2015—Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.

Read more


Vanderbilt University honors 28 as emeriti faculty

May. 8, 2015—Twenty-eight retiring faculty members were recognized during Vanderbilt’s Commencement ceremony May 8, when the university honored their years of service and bestowed on them the title of emeritus or emerita faculty.

Read more


Kids more likely to react to blood transfusions

May. 4, 2015—Pediatric patients have a significantly higher incidence of transfusion reactions compared to adults, according to a study by Vanderbilt University researchers.

Read more


RNA defects in multiple sclerosis

Apr. 30, 2015—Vanderbilt researchers have discovered that profound defects exist in the integrity of structural RNA molecules in patients with relapsing remitting multiple sclerosis.

Read more


Cates lands grant to study desmoid tumor genetic factors

Apr. 16, 2015—The Desmoid Tumor Research Foundation (DTRF) has awarded Justin Cates, M.D., Ph.D., associate professor of Pathology, Microbiology and Immunology, with one of its five research grants for his work studying growth/recurrence determinants related to genetic factors in desmoid-type fibromatosis (DTF) patients.

Read more


Contributors to coronavirus ‘fitness’

Feb. 24, 2015—Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS.

Read more


Targeting HIV’s “cap”

Feb. 10, 2015—New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target.

Read more


Vanderbilt-led team studies blood test for prostate cancer

Jan. 5, 2015—Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.

Read more


Target for atherosclerosis therapies

Dec. 17, 2014—A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression.

Read more


Page 7 of 12« First...4567891011...Last »

Upcoming Events

MORE EVENTS »